SELLAS Life Sciences (SLS) Receivables (2022)
SELLAS Life Sciences (SLS) has disclosed Receivables for 3 consecutive years, with $1.0 million as the latest value for Q1 2022.
- Quarterly Receivables changed N/A to $1.0 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Mar 2022, changed N/A year-over-year, with the annual reading at $250000.0 for FY2012, N/A changed from the prior year.
- Receivables for Q1 2022 was $1.0 million at SELLAS Life Sciences, down from $1.5 million in the prior quarter.
- The five-year high for Receivables was $1.0 million in Q1 2022, with the low at $1.0 million in Q1 2022.